NCT01951222View on ClinicalTrials.gov

Bronchodilator Properties and Safety in Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Asthma

Interventions

DRUG

V0162

OTHER

Placebo

Trial Locations (1)

Unknown

CRO, Gauting

All Listed Sponsors

lead

Pierre Fabre Medicament

INDUSTRY

NCT01951222 - Bronchodilator Properties and Safety in Asthma | Biotech Hunter | Biotech Hunter